Show simple item record

dc.contributor.authorHerman, Patricia
dc.contributor.authorDodds, Sally
dc.contributor.authorLogue, Melanie
dc.contributor.authorAbraham, Ivo
dc.contributor.authorRehfeld, Rick
dc.contributor.authorGrizzle, Amy
dc.contributor.authorUrbine, Terry
dc.contributor.authorHorwitz, Randy
dc.contributor.authorCrocker, Robert
dc.contributor.authorMaizes, Victoria
dc.date.accessioned2016-05-20T09:05:14Z
dc.date.available2016-05-20T09:05:14Z
dc.date.issued2014en
dc.identifier.citationHerman et al. BMC Complementary and Alternative Medicine 2014, 14:132 http://www.biomedcentral.com/1472-6882/14/132en
dc.identifier.doi10.1186/1472-6882-14-132en
dc.identifier.urihttp://hdl.handle.net/10150/610366
dc.description.abstractBACKGROUND:Integrative medicine (IM) is a patient-centered, healing-oriented clinical paradigm that explicitly includes all appropriate therapeutic approaches whether they originate in conventional or complementary medicine (CM). While there is some evidence for the clinical and cost-effectiveness of IM practice models, the existing evidence base for IM depends largely on studies of individual CM therapies. This may in part be due to the methodological challenges inherent in evaluating a complex intervention (i.e., many interacting components applied flexibly and with tailoring) such as IM.METHODS/DESIGN:This study will use a combination of observational quantitative and qualitative methods to rigorously measure the health and healthcare utilization outcomes of the University of Arizona Integrative Health Center (UAIHC), an IM adult primary care clinic in Phoenix, Arizona. There are four groups of study participants. The primary group consists of clinic patients for whom clinical and cost outcomes will be tracked indicating the impact of the UAIHC clinic (n=500). In addition to comparing outcomes pre/post clinic enrollment, where possible, these outcomes will be compared to those of two matched control groups, and for some self-report measures, to regional and national data. The second and third study groups consist of clinic patients (n=180) and clinic personnel (n=15-20) from whom fidelity data (i.e., data indicating the extent to which the IM practice model was implemented as planned) will be collected. These data will be analyzed to determine the exact nature of the intervention as implemented and to provide covariates to the outcomes analyses as the clinic evolves. The fourth group is made up of patients (n=8) whose path through the clinic will be studied in detail using qualitative (periodic semi-structured interviews) methods. These data will be used to develop hypotheses regarding how the clinic works.DISCUSSION:The US health care system needs new models of care that are more patient-centered and empower patients to make positive lifestyle changes. These models have the potential to reduce the burden of chronic disease, lower the cost of healthcare, and offer a sustainable financial paradigm for our nation. This protocol has been designed to test whether the UAIHC can achieve this potential.TRIAL REGISTRATION:Clinical Trials.gov NCT01785485.
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.biomedcentral.com/1472-6882/14/132en
dc.rights© 2014 Herman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).en
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/
dc.subjectIntegrative medicineen
dc.subjectObservational studyen
dc.subjectStudy protocolen
dc.subjectFidelity monitoringen
dc.subjectImplementation fidelityen
dc.subjectComplex interventionsen
dc.subjectComparative effectiveness researchen
dc.subjectHealthcare utilizationen
dc.subjectCost outcomesen
dc.subjectHealth services researchen
dc.titleIMPACT - Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic modelen
dc.typeArticleen
dc.identifier.eissn1472-6882en
dc.contributor.departmentHealth Unit, the RAND Corporation, Santa Monica, CA, USAen
dc.contributor.departmentArizona Center for Integrative Medicine, University of Arizona College of Medicine, Tucson, AZ, USAen
dc.contributor.departmentUniversity of Arizona College of Nursing, Tucson, AZ, USAen
dc.contributor.departmentCenter for Health Outcomes & PharmacoEconomic Research (HOPE), University of Arizona College of Pharmacy, Tucson, AZ, USAen
dc.identifier.journalBMC Complementary and Alternative Medicineen
dc.description.collectioninformationThis item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2018-09-11T11:03:30Z
html.description.abstractBACKGROUND:Integrative medicine (IM) is a patient-centered, healing-oriented clinical paradigm that explicitly includes all appropriate therapeutic approaches whether they originate in conventional or complementary medicine (CM). While there is some evidence for the clinical and cost-effectiveness of IM practice models, the existing evidence base for IM depends largely on studies of individual CM therapies. This may in part be due to the methodological challenges inherent in evaluating a complex intervention (i.e., many interacting components applied flexibly and with tailoring) such as IM.METHODS/DESIGN:This study will use a combination of observational quantitative and qualitative methods to rigorously measure the health and healthcare utilization outcomes of the University of Arizona Integrative Health Center (UAIHC), an IM adult primary care clinic in Phoenix, Arizona. There are four groups of study participants. The primary group consists of clinic patients for whom clinical and cost outcomes will be tracked indicating the impact of the UAIHC clinic (n=500). In addition to comparing outcomes pre/post clinic enrollment, where possible, these outcomes will be compared to those of two matched control groups, and for some self-report measures, to regional and national data. The second and third study groups consist of clinic patients (n=180) and clinic personnel (n=15-20) from whom fidelity data (i.e., data indicating the extent to which the IM practice model was implemented as planned) will be collected. These data will be analyzed to determine the exact nature of the intervention as implemented and to provide covariates to the outcomes analyses as the clinic evolves. The fourth group is made up of patients (n=8) whose path through the clinic will be studied in detail using qualitative (periodic semi-structured interviews) methods. These data will be used to develop hypotheses regarding how the clinic works.DISCUSSION:The US health care system needs new models of care that are more patient-centered and empower patients to make positive lifestyle changes. These models have the potential to reduce the burden of chronic disease, lower the cost of healthcare, and offer a sustainable financial paradigm for our nation. This protocol has been designed to test whether the UAIHC can achieve this potential.TRIAL REGISTRATION:Clinical Trials.gov NCT01785485.


Files in this item

Thumbnail
Name:
1472-6882-14-132.pdf
Size:
305.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2014 Herman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).
Except where otherwise noted, this item's license is described as © 2014 Herman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).